In Pain relief Proxyvon 400mg/65mg Capsule is used to treat moderate to severe pain in conditions like menstrual cramp, arthritis, headache and muscle aches. It works by reducing substances in the body that causes pain. Taking Proxyvon 400mg/65mg Capsule will reduce discomfort associated with the above painful conditions and make you feel better. Take Proxyvon 400mg/65mg Capsule by mouth as directed by your doctor, usually every 4 to 6 hours as needed for pain relief.
It is unsafe to consume alcohol with Proxyvon 400mg/65mg Capsule.
Information regarding the use of Proxyvon 400mg/65mg Capsule during pregnancy is not available. Please consult your doctor.
Proxyvon 400mg/65mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Even small doses of Proxyvon 400mg/65mg Capsule can cause infant sleepiness and decreased/altered brain function.
It is not known whether Proxyvon 400mg/65mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Proxyvon 400mg/65mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Proxyvon 400mg/65mg Capsule may be needed. Please consult your doctor. Use of Proxyvon 400mg/65mg Capsule is not recommended in patients with end stage kidney disease.
Proxyvon 400mg/65mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Proxyvon 400mg/65mg Capsule may be needed. Please consult your doctor.
If you miss a dose of Proxyvon 400mg/65mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Radico Remedies || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Laborate Pharmaceuticals India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jagsonpal Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)